| Completed | Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients Multiple Sclerosis | Phase 4 | 2012-11-01 |
| Completed | Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a Parkinson Disease | Phase 1 | 2011-09-01 |
| Completed | Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls Parkinson Disease, Alzheimer Disease | Phase 1 | 2011-08-01 |
| Completed | Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subj Parkinson Disease | Phase 1 | 2011-05-01 |
| Completed | Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ Alzheimer Disease | EARLY_Phase 1 | 2010-12-01 |
| Completed | Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558 Alzheimer Disease | EARLY_Phase 1 | 2010-09-01 |
| Completed | Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions Alzheimer Disease | Phase 1 | 2010-03-01 |
| Terminated | Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions Alzheimer Disease, Parkinson Disease, Multiple Sclerosis | Phase 1 | 2009-11-01 |
| Terminated | Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513 Alzheimer Disease | EARLY_Phase 1 | 2009-10-01 |
| Completed | Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions Alzheimer Disease, Parkinson Disease, Multiple Sclerosis | Phase 1 | 2009-08-01 |
| Completed | Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects Parkinson Disease, Huntington Disease | Phase 1 | 2009-07-01 |
| Completed | A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions Parkinson Disease, Huntington Disease, Autistic Spectrum Disorders | Phase 1 | 2009-03-01 |
| Terminated | Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Diseas Alzheimer's Disease | Phase 1 | 2009-03-01 |
| Terminated | Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects Alzheimer's Disease | Phase 1 | 2009-01-01 |
| Terminated | Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition Alzheimer's Disease | Phase 1 | 2008-04-01 |
| Terminated | Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition Alzheimer Disease | Phase 1 | 2008-03-01 |
| Terminated | Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subj Parkinson Disease, Alzheimer Disease, Healthy Controls | Phase 1 | 2008-01-01 |
| Completed | Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Alzheimer Disease | Phase 1 | 2007-09-01 |
| Terminated | Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects Alzheimer Disease | Phase 1 | 2007-08-01 |
| Terminated | Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects Alzheimer Disease | Phase 1 | 2007-08-01 |
| Completed | Development of Cognitive Assessment Tools in Parkinson Disease Parkinson Disease | EARLY_Phase 1 | 2007-07-01 |
| Terminated | Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects Depression | Phase 1 | 2007-05-01 |
| Completed | Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects Alzheimers Disease | Phase 1 | 2007-04-01 |
| Completed | Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheime Alzheimer Disease, Parkinson Disease | Phase 2 | 2007-02-01 |
| Terminated | Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects and Parkinson Disease Patients Parkinson Disease | Phase 1 | 2007-01-01 |
| Completed | Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease Parkinson Disease | Phase 2 | 2006-11-01 |
| Completed | Evaluation of 5-[123I]-A-85380 and SPECT Imaging in Individuals With Parkinsons Disease Parkinson Disease | Phase 2 | 2006-11-01 |
| Unknown | A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease Parkinson Disease | Phase 2 | 2006-11-01 |
| Completed | The Study of the Impact of Disclosing Imaging Study Information to Trial Participants Parkinsonian Syndrome, Parkinson | — | 2006-07-01 |
| Completed | Biodistribution and Safety of a Radiopharmaceutical in Healthy Subjects Neurodegenerative Diseases | Phase 1 | 2006-04-01 |
| Completed | Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain Alzheimer Disease | Phase 1 | 2006-02-01 |
| Completed | Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease Parkinson's Disease, Parkinsonian Syndrome | Phase 2 | 2006-01-01 |
| Completed | Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families Parkinson Disease, Parkinsonian Syndrome | Phase 2 | 2006-01-01 |
| Completed | Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Parkinson Disease, Parkinsonian Syndrome | N/A | 2005-01-01 |
| Completed | A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients Parkinson Disease, Parkinsonian Syndrome | — | 2004-10-01 |
| Completed | Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease Parkinson Disease, Parkinsonian Syndrome | Phase 2 | 2004-02-01 |
| Completed | A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease Parkinson's Disease, Parkinsonian Syndrome | — | 2003-05-01 |
| Completed | Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty Parkinsonian Syndrome | Phase 2 | 2003-02-01 |
| Completed | A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Dise Parkinsonian Syndrome | Phase 2 | 2001-03-01 |
| Completed | Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression Parkinson Disease | Phase 2 | 2000-04-01 |
| Completed | Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome Parkinson's Disease, Parkinsonian Syndrome | Phase 2 | 1992-09-01 |